These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 17113137

  • 1. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Kjaerbye-Thygesen A, Gayther S, Jacobs IJ, Høgdall CK.
    Gynecol Oncol; 2007 Mar; 104(3):508-15. PubMed ID: 17113137
    [Abstract] [Full Text] [Related]

  • 2. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Gayther S, Jacobs IJ, Høgdall CK.
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 4. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Nørgaard-Pedersen B, Høgdall CK.
    Cancer; 2003 Jul 01; 98(1):66-73. PubMed ID: 12833457
    [Abstract] [Full Text] [Related]

  • 5. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.
    Begum FD, Høgdall CK, Kjaer SK, Christensen L, Blaakaer J, Bock JE, Glud E, Høyer-Hansen G, Ring-Larsen H, Høgdall EV.
    Anticancer Res; 2004 Jul 01; 24(3b):1981-5. PubMed ID: 15274388
    [Abstract] [Full Text] [Related]

  • 6. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
    Simon I, Katsaros D, Rigault de la Longrais I, Massobrio M, Scorilas A, Kim NW, Sarno MJ, Wolfert RL, Diamandis EP.
    Gynecol Oncol; 2007 Aug 01; 106(2):334-41. PubMed ID: 17498784
    [Abstract] [Full Text] [Related]

  • 7. P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV, Kjaer SK, Blaakaer J, Christensen L, Glud E, Vuust J, Høgdall CK.
    Gynecol Oncol; 2006 Jan 01; 100(1):76-82. PubMed ID: 16183105
    [Abstract] [Full Text] [Related]

  • 8. Ovarian vein vs peripheral blood CA125 serum levels: a comparative study.
    Podnos YD, Gamboa G, Kurosaki T, Buller R, Walker JL, Manetta A.
    Gynecol Oncol; 1997 Jul 01; 66(1):71-4. PubMed ID: 9234924
    [Abstract] [Full Text] [Related]

  • 9. Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Høgdall CK.
    APMIS; 2010 Aug 01; 118(8):557-64. PubMed ID: 20666736
    [Abstract] [Full Text] [Related]

  • 10. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
    Tan XJ, Lang JH, Shen K, Wang L, Wu M, Xu XY.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 01; 43(1):9-12. PubMed ID: 18366924
    [Abstract] [Full Text] [Related]

  • 11. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD, Høgdall E, Kjaer SK, Blaakaer J, Christensen IJ, Christensen L, Høgdall C.
    Gynecol Oncol; 2009 May 01; 113(2):221-7. PubMed ID: 19261323
    [Abstract] [Full Text] [Related]

  • 12. The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer.
    Høgdall CK, Nørgaard-Pedersen B, Mogensen O.
    Anticancer Res; 2002 May 01; 22(3):1765-8. PubMed ID: 12168866
    [Abstract] [Full Text] [Related]

  • 13. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
    Dong L, Cui H, Li XP, Sun LF, Chang XH, Liang XD, Zhu HL.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 01; 43(1):5-8. PubMed ID: 18366923
    [Abstract] [Full Text] [Related]

  • 14. Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study.
    Heeran MC, Høgdall CK, Kjaer SK, Christensen L, Blaakaer J, Christensen IJ, Hogdall EV.
    APMIS; 2012 Oct 01; 120(10):846-54. PubMed ID: 22958293
    [Abstract] [Full Text] [Related]

  • 15. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M, Arsenijević S, Lukić G, Arsenijević N, Ristić P, Pavlović S, Popović S, Baskić D.
    J BUON; 2007 Oct 01; 12(1):99-104. PubMed ID: 17436409
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.
    Høgdall EV, Kjaer SK, Glud E, Christensen L, Blaakaer J, Vuust J, Bock JE, Norgaard-Pedersen B, Hogdall CK.
    Anticancer Res; 2003 Oct 01; 23(4):3397-404. PubMed ID: 12926080
    [Abstract] [Full Text] [Related]

  • 17. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
    Cai Z, Li YF, Liu FY, Feng YL, Hou JH, Zhao MQ.
    Ai Zheng; 2007 Mar 01; 26(3):312-7. PubMed ID: 17355798
    [Abstract] [Full Text] [Related]

  • 18. Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage.
    Fures R, Buković D, Hodek B, Klarić B, Herman R, Grubisić G.
    Coll Antropol; 1999 Jun 01; 23(1):189-94. PubMed ID: 10402722
    [Abstract] [Full Text] [Related]

  • 19. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
    Simojoki M, Santala M, Risteli J, Risteli L, Kauppila A.
    Anticancer Res; 2000 Jun 01; 20(6C):4655-60. PubMed ID: 11205196
    [Abstract] [Full Text] [Related]

  • 20. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
    Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH.
    Clin Cancer Res; 2004 Jul 15; 10(14):4761-8. PubMed ID: 15269150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.